• Feng Yu, Mengxue Xin, Na Huang, Taotao Zhang, JianHui Lu, and Nan Liu.
• The First Affiliated Hospital of Guangzhou University of Chinese Medicine.
• Medicine (Baltimore). 2021 Feb 19; 100 (7): e24773e24773.

BackgroundShuxuetong injection (SXT) is a Chinese medicine injection and has been widely used for the treatment of acute myocardial infarction (AMI) in Asia. However, whether SXT has a definite efficacy and safety is poorly understood. The aim of our study was to clarify the effect of SXT on clinical symptoms alliavation and survival in AMI patients.MethodsA systematic reviews of SXT combined with conventional therapy treating AMI will be searched in 8 electronic databases including PubMed, Cochrane Library, Embase, Wanfang Database, China Biology Medicine (CBM), Google Scholar, Chinese Scientific Journal Database (VIP), and China National Knowledge Infrastructure (CNKI), from inception to December 2020. The literature will extracted by 2 researchers independently and the methodological quality of the included study will be evaluated. We will use the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to evaluate the evidence quality of the included literature. RevMan software (version 5.3) will be applied for the original research data synthesis.ResultsThe results of our study will be published in a peer reviewed journal.ConclusionOur meta-analysis will provide the latest evidence to determine whether SXT is an effective intervention for AMI patients.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

11 keywords...

hide…